Tag: Brisbane

Manufacturing became the largest occupier group in Australia's industrial and logistics property market during the second quarter of 2026, accounting for 37 per cent of national take-up, as the sector continued to record solid leasing activity and the national vacancy rate declined to 4.8 per cent, according to new research from JLL.

The Queensland Government has announced a $4.5 million investment in new heavy-lift infrastructure at Brisbane's Cairncross Dockyard, saying the funding will strengthen the state's defence and maritime manufacturing capability while supporting future ship maintenance and sustainment work.

Australian Manufacturing Week 2026 has concluded in Brisbane after three days of showcasing advanced manufacturing technologies, automation and industry innovation, with organisers highlighting strong...

Australian Manufacturing Week 2026 opened today in Brisbane, bringing together manufacturers, technology providers and industry leaders for three days focused on manufacturing innovation, automation and emerging technologies, according to organisers AMTIL.

The Australian Manufacturing Growth Centre (AMGC) will host a workshop focused on helping manufacturers begin or strengthen their export capability during Australian Manufacturing Week in Brisbane on 13 May 2026.

Seven NSW manufacturers will showcase their products and expertise at this year’s Australian Manufacturing Week 2026 in Brisbane, with support from the NSW Government as part of efforts to promote the state’s advanced manufacturing sector.

Australia’s manufacturing sector continues to play a critical role in the national economy, underpinned by ongoing investment in advanced technologies, automation, and high-value production. 

Salvos Stores has opened a textile recovery facility in Brisbane, describing the site as the first of its kind in Australia and part of broader efforts to reduce clothing waste and support circular economy initiatives.

Vaxxas Pty Ltd has secured around $90 million in new funding to accelerate the commercialisation and manufacturing of its needle-free vaccine delivery technology.

Translational Research Institute (TRI) has officially unveiled its new biomedical manufacturing facility in Brisbane, named ENTRI, in a move the Institute says will help unlock biomanufacturing capability and accelerate the commercialisation of Australian medical innovations.